CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today announced it has signed a definitive agreement to purchase Cardiac Science Corporation (CSC), a leading provider of automated external defibrillators (AEDs), related services, and accessories. CSC is a portfolio company of Aurora Resurgence, a Los Angeles-based private equity investment firm.
“We are excited about the alignment of our two companies and our combined ability to put life-saving technology in the hands of more lay rescuers and first responders answering medical emergencies,” said Elijah A. White, President of ZOLL Resuscitation. “ZOLL and Cardiac Science have been delivering AED solutions for the better part of two decades. As we look to the future together, our combined organization will provide more choices to current and future customers. This includes continuing to actively promote, market, and supply the Powerheart® line of AEDs and Rescue Ready® services in addition to our ZOLL AEDs and PlusTrac™ program management. Moving forward, ZOLL plans to continue ongoing development and to introduce new products for both Powerheart and ZOLL brands.”
“Joining ZOLL is the right opportunity for our business, our people, and our customers,” said Dev Kurdikar, President and CEO of Cardiac Science. “We are enthusiastic that our combined portfolios will be able to address a greater range of needs for our customers and look forward to accelerated innovation to meet persistent needs in the community for these vital emergency services. By expanding the reach of our current and future line of Powerheart AEDs, we will be able to further fulfill our mission of saving lives.”
White highlighted that one of the benefits of joining forces is the expansion of ZOLL’s lifesaving AED management programs to a larger number of AEDs. ZOLL’s AED Link™ connects first responders with the closest available AED. Today, publicly available AEDs are sometimes not retrieved and used because bystanders cannot see them and 9-1-1 dispatchers are unaware they are nearby. ZOLL’s technology enables dispatchers to communicate the locations of registered AEDs to callers reporting potential sudden cardiac arrest incidents. With the addition of Cardiac Science to the AED Link program more 9-1-1 agencies will be able to help put AEDs in the hands of laypersons and first responders to support life-saving action.
Kurdikar added, “Cardiac Science has an exciting pipeline of innovative products that are anticipated to be launched beginning this year. These new technologies, which advance ease of use or performance, can be deployed in ZOLL AEDs and thus benefit more SCA victims across the world.”
“Combining ZOLL’s PlusTrac program management and Cardiac Science’s Rescue Ready Services offering will expand ZOLL’s database of AED information,” White added, “and in so doing, improve first responder access to AEDs and improve the response to victims of cardiac arrest.”
The acquisition is subject to regulatory approval and other customary closing conditions. Additional terms of the agreement are not being disclosed at this time.
About Sudden Cardiac Arrest
Sudden cardiac arrest (SCA), an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs, claims more than 350,000 lives each year in the U.S. It is the leading cause of unexpected death in the world and strikes without warning. Timing is critical to survival. If a victim does not receive CPR and early defibrillation from an AED, chances of survival decrease 10% with each passing minute.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets automated external defibrillators (AEDs) and related parts, components and accessories. The company also provides a comprehensive portfolio of training, maintenance, and support services for AED customers. Cardiac Science has executive offices in Deerfield, Wisconsin. The company has operations in North America, Europe, and Asia and has an installed base of over 500,000 units in nearly 100 countries worldwide. Cardiac Science is a portfolio company of Los Angeles-based Aurora Resurgence, a leading private equity firm focused on investing in middle market companies. For information, call 1.800.426.0337 or contact email@example.com.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2019 ZOLL Medical Corporation. All rights reserved. AED Link, PlusTrac and ZOLL are trademarks and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.